Protocol Ledger

NCT03851445 · Phase II/III · RECRUITING

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Interventional Phase II/III clinical trial protocol NCT03851445 sponsored by SWOG Cancer Research Network in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-02-06 Enrollment: 10,000 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT03851445
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)10,000 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03851445
Protocol FieldVerified Registry Value
NCT IdentifierNCT03851445
Consolidated Lead SponsorSWOG Cancer Research Network
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II/III
Overall Recruitment StatusRECRUITING
Registered Enrollment10,000 participants (ESTIMATED)
Registered Start Date2019-02-06
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT03851445
Hospital Research SiteLocationSite Profile
Anchorage Associates in Radiation MedicineAnchorage, AKOpen Hospital Dossier ->
Anchorage Radiation Therapy CenterAnchorage, AKOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI